Pulmonary Function Testing (PFT) is an integral part of respiratory medicine that provides valuable insights into lung function. Its interpretation, however, can be complex, necessitating a comprehensive understanding for accurate diagnosis and management.
Interpretation of PFTs involves the analysis of several parameters, including Forced Vital Capacity (FVC), Forced Expiratory Volume in one second (FEV1), and the FEV1/FVC ratio. Abnormalities in these can indicate obstructive or restrictive lung diseases.
Obstructive lung diseases, such as Chronic Obstructive Pulmonary Disease (COPD) and asthma, are characterized by reduced FEV1 and FEV1/FVC ratio. In contrast, restrictive diseases like pulmonary fibrosis present with a reduced FVC but normal or increased FEV1/FVC ratio.
While PFTs provide objective data, they should always be interpreted in the context of the patient's clinical presentation. Symptoms, physical examination findings, and radiological investigations should be integrated with PFT results for a holistic approach to patient care.
Interpreting PFTs is a skill that requires a solid understanding of respiratory physiology and pathology. As healthcare professionals, staying adept at this skill helps us provide optimal patient care, ensuring accurate diagnosis and treatment of respiratory conditions.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation